CAS Search
Related Chemical Product
Buy Chemical NO: 9012-76-4
  • Urgent Purchase CAS NO.:9012-76-4
  • Please post your buying leads! Our suppliers will contact you later!
  • For suppliers to better understand your request, enter more info here.

* Product Name:
CAS No.:
* Quantity:
 
 Metric Ton     Kilogram    Gram    Pound
* Valid For:
 5 Days    15    1 Month    3 Month    6 Month    1 Year
* Description:

Max 2000 characters.  Please enter detailed description for the product.
* Email:
 

Chitosan ( CASNO:9012-76-4 )

Identification and Related Records
Name:
Chitosan
CAS Registry number:
9012-76-4
Synonyms:
Flonac C
Chitosan H
Marinkaito F 05N
Marinkaito F 05S
KW 5
TKS 250N
Sea Cure 123
FCM 117
SK 10 (polysaccharide)
HC 1 (polysaccharide)
North Chitosan MC 1
OTS 2
Sea Cure 143
SK 200
Sea Cure 340
HI-DENSITY CHITOSAN
Chitopearl BCW 3505
Chiton (molluscan common name)Chitopearl 3510
Chitopearl BCW 3507
Hiset KW 5
WOT Recovery Floc T
Kytex M
Sea Cure 243
Chitosan EL
Hydagen HCMF
Profloc 320
EINECS(EC#):
222-311-2
Molecular Formula:
Unspecified
Molecular Weight:
179.17112
Inchi:
InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
InChIKey:
MSWZFWKMSRAUBD-QZABAPFNSA-N
Canonical SMILES:
C(C1C(C(C(C(O1)O)N)O)O)O
Isomers smiles:
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O
Chemical and Physical Properties
Appearance:
faintly beige solid
Density:
1.75g/cm3
Melting Point:
88 deg C
Refractive Index:
1.7
Water:
insoluble in water
Solubilities:
insoluble in water
Stability:
Stable. Incompatible with strong oxidizing agents.
Storage temp:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Computed Properties:
Molecular Weight:179.17112 [g/mol]
Molecular Formula:C6H13NO5
XLogP3-AA:-2.8
H-Bond Donor:5
H-Bond Acceptor:6
Rotatable Bond Count:1
Exact Mass:179.079373
MonoIsotopic Mass:179.079373
Topological Polar Surface Area:116
Heavy Atom Count:12
Formal Charge:0
Complexity:155
Isotope Atom Count:0
Defined Atom Stereocenter Count:5
Undefined Atom Stereocenter Count:0
Defined Bond Stereocenter Count:0
Undefined Bond Stereocenter Count:0
Covalently-Bonded Unit Count:1
Feature 3D Acceptor Count:5
Feature 3D Donor Count:5
Feature 3D Cation Count:1
Feature 3D Ring Count:1
Effective Rotor Count:2.2
Conformer Sampling RMSD:0.6
CID Conformer Count:6
Safety and Handling
Hazard Codes:
Xn
Risk Statements:
20/21/22-36/37/38
Safety Statements:
S24/25
Safety:
Hazard Codes:Xn
Risk Statements:20/21/22-36/37/38
20/21/22:Harmful by inhalation, in contact with skin and if swallowed
36/37/38:Irritating to eyes, respiratory system and skin
Safety Statements:24/25-36-26
24/25:Avoid contact with skin and eyes
36:Wear suitable protective clothing
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
WGK Germany:-
Formulations/Preparations:
The three forms of glucosamine available commercially are glucosamine hydrochloride, glucosamine sulfate and N-acetyl glucosamine.
Specification:
The Chitosan, with the cas registry number 9012-76-4, is a kind of white colorless solid. This is stable but incompatible with strong oxidizing agents. And its product categories are including Miscellaneous Natural Products; Biochemistry; Polysaccharides; Sugars; Nutritional Supplements; Dextrins Sugar & Carbohydrates. The physical properties of this chemical are as follows: (1)# of Rule of 5 Violations: 3; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 1; (5)ACD/KOC (pH 7.4): 1; (6)#H bond acceptors: 48; (7)#H bond donors: 37; (8)#Freely Rotating Bonds: 55; (9)Polar Surface Area: 808; (10)Index of Refraction: 1.701; (11)Molar Refractivity: 336.803 cm3; (12)Molar Volume: 870.564 cm3; (13)Polarizability: 133.519 ×10-24 cm3; (14)Surface Tension: 122.211 dyne/cm; (15)Density: 1.753 g/cm3; (16)Exact Mass: 179.079373; (17)MonoIsotopic Mass: 179.079373; (18)Topological Polar Surface Area: 116; (19)Heavy Atom Count: 12; (20)Complexity: 155. The production method of this chemical is below: Add 20g Chitosan into the 300mL 50% NaOH solvent and wait for its complete infiltration; Then heat to 95℃ for about 1.5 hours, filter out the alkali liquor and then wash to be neutral; Lastly cool and dry to have colorless transparent schistose products 15.6g. As to its usage, it is widely applied in many ways. It could be used as antistaling agent which is usually used in food industry, and thickening agent, flocculating agent; It could also be used in pharmaceutic, agricultural seed, daily expenses, waste water treatment. When you are dealing with this chemical, you should be very cautious. Being a kind of harmful chemicals, it may cause damage to health. If by inhalation, in contact with skin and if swallowed, it is dangerous. Then it is irritating to eyes, respiratory system and skin. Therefore, you shoud take the following instructions. Wear suitable protective clothing, and then avoid contacting with skin and eyes. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice. In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C(C1C(C(C(C(O1)O)N)O)O)O
(2)Isomeric SMILES: C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O
(3)InChI: InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,-/m1/s1
(4)InChIKey: MSWZFWKMSRAUBD-QZABAPFNSA-N?
Octanol/Water Partition Coefficient:
log Kow = -4.2 (est)
Disposal Methods:
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Use and Manufacturing
Use and Manufacturing:
Methods of Manufacturing

Found in chitin, in mucoproteins, and in mucopolysaccharides.
Usage:
Claimed to have the ability to retain fats and cholesterol in the stomach.
Biomedical Effects and Toxicity
Therapeutic Uses:
Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) evaluated their efficacy and safety as a treatment for knee pain from osteoarthritis. 1583 patients with symptomatic knee osteoarthritis /were randomly assigned/ to receive 1500 mg of glucosamine daily, 1200 mg of chondroitin sulfate daily, both glucosamine and chondroitin sulfate, 200 mg of celecoxib daily, or placebo for 24 weeks. Up to 4000 mg of acetaminophen daily was allowed as rescue analgesia. Assignment was stratified according to the severity of knee pain (mild [N=1229] vs. moderate to severe [N=354]). The primary outcome measure was a 20 percent decrease in knee pain from baseline to week 24. The mean age of the patients was 59 years, and 64 percent were women. Overall, glucosamine and chondroitin sulfate were not significantly better than placebo in reducing knee pain by 20 percent. As compared with the rate of response to placebo (60.1 percent), the rate of response to glucosamine was 3.9 percentage points higher (P=0.30), the rate of response to chondroitin sulfate was 5.3 percentage points higher (P=0.17), and the rate of response to combined treatment was 6.5 percentage points higher (P=0.09). The rate of response in the celecoxib control group was 10.0 percentage points higher than that in the placebo control group (P=0.008). For patients with moderate-to-severe pain at baseline, the rate of response was significantly higher with combined therapy than with placebo (79.2 percent vs. 54.3 percent, P=0.002). Adverse events were mild, infrequent, and evenly distributed among the groups. Glucosamine and chondroitin sulfate alone or in combination did not reduce pain effectively in the overall group of patients with osteoarthritis of the knee. Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain. [Clegg DO et al; New Eng J Med 354: 795-808 (2006)]
Biomedical Effects and Toxicity:
Information on the absorption and serum pharmacokinetics for dietary glucosamine is very limited, and in some case, the available data are contradictory. For example, in one series of studies, (14)C-glucosamine was given orally to rats, dogs, and humans, and in all cases, the radiolabel was described as "efficiently" absorbed, reaching a plasma peak after about 4 hours. A high percentage of the radiolabel (about 35%) was excreted in the urine, and a similar amount was last in expired air. On the other hand, the laboratory that conducted this experiment was unable to detect chemical amounts of glucosamine in human serum after a single oral dose at 100 mg/kg (five times the clinical dose) using a chromatographic assay with a limit of detection of about 14 uM. This suggests that the bioavailable glucosamine in human serum after the normal recommended dosage (20 mg/kg) is well below 10 uM.
About 90% of glucosamine administered orally as a glucosamine salt get absorbed from the small intestine, and from there it is transported via the portal circulation to the liver. It appears that a significant fraction of the ingested glucosamine is catabolized by first-pass metabolism in the liver. Free glucosamine is not detected in the serum after oral intake, and it si not presently known how much of an ingested dose is taken up in the joints in humans. Some uptake in the articular cartilage is seen in animal studies.
Twelve healthy volunteers received three consecutive once-daily oral administrations of glucosamine sulfate soluble powder at the doses of 750, 1,500, and 3,000 mg, in an open, randomised, cross-over fashion. Glucosamine was determined in plasma collected up to 48 hr after the last dose. ... Endogenous plasma levels of glucosamine were detected (10.4-204 ng/ml, with low intra-subject variability). Glucosamine was rapidly absorbed after oral administration and its pharmacokinetics were linear in the dose range 750-1,500 mg, but not at 3,000 mg, where the plasma concentration-time profiles were less than expected based on dose-proportionality. Plasma levels increased over 30-folds from baseline and peaked at about 10 microM with the standard 1,500 mg once-daily dosage. Glucosamine distributed to extravascular compartments and its plasma concentrations were still above baseline up to the last collection time. [Persiani S et al; Osteoarthritis Cartilage 13 (12): 1041-9 (2005)] PubMed Abstract
Eighteen subjects with osteoarthritis were given 1,500 mg of commercial glucosamine sulphate after an overnight fast, and serum was then obtained at baseline and every 15-30 minutes over 3 hours, and additionally, from two subjects at 5 and 8 hours. Urine samples were collected at baseline and 3 hours after ingestion from three subjects. Baseline glucosamine was below the detection limit of 0.5 umol/L for all subjects, but after ingestion, glucosamine was detected in 17/18 subjects, beginning to rise at 30-45 minutes to a maximum at 90-180 minutes, with a range of 1.9-11.5 umol/L (0.34-2 ug/ml). [Bittee BA et al; Ann Rheum Dis 65 (2): 222-6 (2006)] PubMed Abstract
The purpose of this study was to determine if glucosamine (GL) hydrochloride (FCHG49) and low molecular weight (LMW) chondroitin sulfate (CS) (TRH122) are absorbed after oral administration to horses. The bioavailability of LMWCS was evaluated by quantifying the total disaccharides found in the plasma following chondroitinase ABC digestion. Two separate studies were conducted. In study 1, ten adult horses received the following four treatments in a randomized crossover fashion: (1) i.v. LMWCS (3 g of 8 kDa), (2) p.o. LMWCS (3 g of 8 kDa), (3) i.v. LMWCS (3 g of 16.9 kDa) and (4) p.o. LMWCS (3 g of 16.9 kDa). Each group received 9 g GL with LMWCS. In a second study, each horse (n=2) was randomly assigned to receive either i.v. administration of GL HCl (9 g) or p.o. administration of GL HCl (125 mg/kg). Blood samples were collected, assayed and pharmacokinetic parameters were determined. GL was absorbed after oral dosing with a mean C(max) of 10.6 (6.9) ug/ml and a mean T(max) of 2.0 (0.7) hr. The extent of absorption of LMWCS after dosing with both the 8.0 and 16.9 kDa provides evidence that LMWCS is absorbed orally. C(max) and AUC were higher (pPubMed Abstract
The purpose of this study was to determine the oral bioavailability and pharmacokinetics of a glucosamine and the disaccharides of chondroitin sulfate after single and multiple-dosing of a glucosamine/chondroitin sulfate combination (Cosamin, Cosequin). Male beagle dogs (n = 8, 12 kg) received the following treatments: (1) IV glucosamine (500 mg)/chondroitin sulfate (400 mg), (2) p.o. glucosamine (1500 mg)/chondroitin sulfate (1200 mg), (3) p.o. glucosamine (2000 mg)/chondroitin sulfate (1600 mg), (4) p.o. glucosamine (1500 mg)/chondroitin sulfate (1200 mg) QD for days 1-7 and p.o. glucosamine (3000 mg)/chondroitin sulfate (2400 mg) from days 8 to 14. Blood samples were collected over 24 hr and glucosamine and the disaccharides of chondroitin sulfate were determined. Pharmacokinetic analysis was performed on glucosamine and total chondroitin sulfate disaccharides and parameters were compared across treatments using ANOVA with post hoc analysis. After the IV administration, glucosamine declined rapidly in a bi-exponential fashion with a mean (+ or - S.D.) elimination t(1/2) of 0.52 (0.25) hr. Glucosamine absorption was relatively fast (C(max) = 8.95 ug/ml, and T(max) 1.5 h after 1500 mg dose) and the mean bioavailability of glucosamine after single dosing was approximately 12%. The extent of absorption of chondroitin sulfate as indicated by the mean C(max) (21.5 ug/ml) and mean AUC (187 ug/ml hr) of total disaccharides after dosing (1600 mg) provides evidence that chondroitin sulfate is absorbed orally. The bioavailability of chondroitin sulfate ranged from 4.8 to 5.0% after single dosing and 200-278% upon multiple dosing. The results of this study show that both glucosamine and chondroitin sulfate (measured as total disaccharides) are bioavailable after oral dosing. In addition, the low molecular weight chondroitin sulfate used in this study displays significant accumulation upon multiple dosing. [Adebowale A et al; Biopharm Drug Dispos 23 (6): 217-25 (2002)] PubMed Abstract
The pharmacokinetics of glucosamine sulfate was investigated in 6 healthy male volunteers (2 per administration route) using (14)C uniformly labelled glucosamine sulfate and administering it in single dose by intravenous (i.v.), intramuscular (i.m.) or oral route. The results show that after i.v. administration the radioactivity due to glucosamine appears in plasma and is rapidly eliminated, with an initial t1/2 of 0.28 hr. 1-2 hr after administration the radioactivity due to glucosamine disappears almost completely and is replaced by a radioactivity originating from plasma proteins, in which glucosamine or its metabolites are incorporated. This radioactivity reaches a peak after 8-10 hr and then declines with a t1/2 of 70 hr. About 28% of the administered radioactivity is recovered in the urine of the 120 hr following the administration and less than 1% is recovered in the feces. After i.m. administration similar pharmacokinetic patterns are observed. After oral administration a proportion close to 90% of glucosamine sulfate is absorbed. Free glucosamine is not detectable in plasma. The radioactivity incorporated in the plasma proteins follows pharmacokinetic patterns which are similar to those after i.v. or i.m. administration, but its concentration in plasma is about 5 times smaller than that after parenteral administration. The AUC after oral administration is 26% of that after i.v., or i.m. administration. The smaller plasma levels of radioactivity after oral administration are probably due to a first pass effect in the liver which metabolizes a notable proportion of glucosamine into smaller molecules and ultimately to CO2, water and urea. [Setnikar I et al; Arzneimittelforschung 43 (10): 1109-13 (1993)] PubMed Abstract
Environmental Fate and Exposure Potential
Environmental Fate/Exposure Summary:
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that glucosamine is expected to have very high mobility in soil(SRC). The pKa of glucosamine is 7.58(3), indicating that this compound will partially exist in cation form in the environment and cations generally absorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of the neutral form of glucosamine from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 7.7X10-16 atm-cu m/mole(SRC), using a fragment constant estimation method(5). Volatilization of the cation from moist soil surfaces will not occur as ionic species do not volatilize. Glucosamine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 9.0X10-8 mm Hg(SRC), determined from a fragment constant method(6). Glucosamine is expected to biodegrade fairly rapidly in aerobic soil environments based on a grab sample study using two different soils where 36 and 56% mineralization and 65 and 70% mineralization were reported after 1 and 8 weeks, respectively(7).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that glucosamine is not expected to adsorb to suspended solids and sediment(SRC). However, glucosamine will exist partially in the cation form at pH values of 5 to 9 based on a pKa of 7.58(5) and cations generally adsorb more strongly to organic carbon and clay than their neutral counterparts(6). Volatilization from water surfaces is not expected(3) for the neutral species based upon an estimated Henry's Law constant of 7.7X10-16 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). Volatilization of the cation from water surfaces is not expected to occur as ionic species do not volatilize. According to a classification scheme(7), an estimated BCF of 3(SRC), from an estimated log Kow of -4.2(8) and a regression-derived equation(9), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Glucosamine is expected to biodegrade fairly rapidly in aerobic water based on a soil grab sample study using two different soils where 36 and 56% mineralization and 65 and 70% mineralization were reported after 1 and 8 weeks, respectively(10).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), glucosamine, which has an estimated vapor pressure of 9.0X10-8 mm Hg at 25 deg C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase glucosamine may be removed from the air by wet or dry deposition(SRC). Glucosamine does not contain a chromophore that absorbs at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(3).
Chemical Company
Utkal Hydrocarbons:
profile: Utkal Hydrocarbons is definitely an ISO 9001:2000 Licensed COMPANY. We're mainly involved in manufacturing and purchase of numerous coal tar by items. Our products includes refined naphthalene balls, light & heavy cresote oil, Furnace Oil and light Diesel oil. 
465724SX54ScsdaAD:
 
ShenZhen OSENON Technology Co.,Ltd:
Company Profile OSENON is a long-term focus on the ultrasonic sensor / ultrasonic transducer development,Website:http://www.osenon-ultrasonicsensor.com, researching application, manufacture and sales company. Our ultrasonic sensor products are widely used in distance detection, burglar alarm, smart toys, liquid and gas flow testing, wind speed and direction detection, automatic control, ultrasonic anemometer and other fields. Because of the stable performance, excellent quality, we got deep trust of customers around the world. OSENON manufacturing plants worldwide total area of 10,000 square meters. We have advanced production and testing equipment, strong technical team and perfect management system. Keeping corporate creed of "creativity, integrity and contribution", and highly dedicated 
Merlin Trade, Ltd:
 
hubei zhenhua chemical co., ltd:
Situated in Huangshi,a city that is in the southwest bank of Yangtze River and renowned for its industies, Hubei Zhenhua Chemical CO., LTD was named: Huangshi Zhenhua Chemical Industry Co.,Ltd, has more then 4 decades history for creating chroium salts. Zhenhua sticks out among 4 esteemed and best c chromic salts production enterprise in china.  
Wuhan hormone manufacture Co.,Ltd:
E are a chemical manufacturer from china and focus on hormone powder anabolic steroids, mainly includes Androgens, estrogens, progestins and its Antagonists, steroid drugs mostly use for bodybuilding muscle, like Anadrol, Anavar, Deca-Durabolin, Dianabol, Equipoise, Halotestin, Masteron, Turinabol, parabolan, Primobolan, Proviron, Sustanon, testosterone, TRENBOLONE, WINSTROL and the like. Our organization capital claims is above 500 million RMB. Based on the GMP standard, the organization has generated 30000 sq.m plant outfitted the advanced equipment. The factory includes a complete Q.a. & Q.c. System. We own several teams of examining instruments rich in efficiency and high sensitivity, such as HPLc, Gc and Ultra violet spectrophotometer to evaluate and control the items. We've the autho 
xinbang:
 
King Quenson Industry Group:
 
China Ocean University Organism Project:
 
Tangyin Dingyuan Engineering Plastics Co., Ltd:
Tangyin Dingyuan Engineering plastics Co., Ltd is really a high-tech businesses involved in the brand new engineering plastics R&D, production and sales service integration . The organization is situated in Yigou industrial areas,Tangyin county, Anyang City,Henan province .the visitors are very convenient.  Company mainly produces series of ultra-high molecular weight polyethylene (UHMWPE) items. The primary items include UHMWPE sheet, UHMWPE fishing fishing rod, UHMWPE Pipe, UHMWPE convey curler, all sorts of slide, slide block,Modified UHMWPE sheet, fishing rod, Tube, ETC. Our items could be broadly utilized in steel, smelting, coking, Electic Energy, chemical, coal, cement, Food, mining, machinery, oil fields, Municipal engineering, marine engineering an 
Anhui Minmetals Development Imp.& Exp. Co.,Ltd:
 
JINHUA SHUNDA PRINTING AND PACKAGING CO.,LTD KM:
Jinhua Shunda Color Printing and Packing Co., Ltd. was established in 1994,Website:http://www.shundapoker.asia, engaged in the printing industry for over 21 years. Focus on the p playing cards industry more than 10 years. Our advanced technology, advanced equipment. Million and built more than 9,000 square feet of standardized production workshop on investment. Our have licenses held by the National Light Industry, the printing business license, trademark printing permit.  
HENAN DOWELL CRANE CO.,LTD NC:
Dowellcrane Machinery?Group is a China-leading group of crane businesses which was founded in 1955,Website:http://www.cranemfr.com, Only one company has 60years manufacture experience. And serving a broad range of customers all over the world to provide a complete set of advanced lifting project, including Gantry crane, Bridge crane, Jib crane, Accessory. Our clients include manufacturing and process industries, shipyards, ports and so on. Regardless of your lifting needs, dowellcrane Machinery?Group is committed to providing you with lifting equipment and services that increase the effectiveness and value of your business. 
Suzhou Gold Ocean Co., Ltd:
Suzhou Gold Ocean Co., Ltd is one of the leading manufacturers and exporters of fountain & waterscape equipments in China who can provide the whole solution of waterscape for clients. Our main fountain types include: Musical Dancing Fountain,Website:http://www.go-fountain.com, Program Control Fountain, Floor Fountain, Floating Fountain, Super-high Spray Fountain, Water Screen Movie, Digital Water Curtain, etc. Main of our services include: fountain design, manufacturing, on-site installation guidance, technical training and after-sale maintenance. With CE and ISO certified and talented R&D team, we are in a position to offer not only novel fountain design, but also reliable quality with competitive cost. Besides, taking client on top priority, we set up considerate after-sale service & m 
romvial s.r.l:
 
Jinan chenghui-shuangda chemical co.,ltd.:
Jinan Chenghui-Shuangda Chemical Co., Ltd. (CHSD), is really a high-tech company developing and creating APIs &lifier chemical intermediates, with nearly 20 proprietary technologies and Patented technologies. founded in 1994, CHSD has greater than 300 employees. since its beginning, CHSD, led through the trend of worldwide pharmaceutical and chemical industry, continues to be meeting market demands in your own home and abroad with humanistic operation and advanced technical pressure. To create its product more complex, CHSD cooperates with lots of famous domestic pharmaceutical plants to build up new drugs, marketing averagely 10 new items every year. To satisfy market demands, CHSD setup one R&D center, two GMP training courses and three pharmaceutical &lifier chemical industr 
Nanjing Legend Pharmaceutical & Chemical Co., Ltd:
Nanjing Legend Pharmaceutical &lifier Chemical Co., Ltd. is really a pharmaceutical &lifier chemical enterprise for that research and production. We offers a factory at Chemical Industrial Park, in Anhui Province in China锛宨n which we are able to produce all sorts of items for example Atazanavir锛孷arenicline锛孡apatinib锛孯itonavir, relative pharmaceutical intermediates . In the same time锛寃e offers own R &lifier D laboratories at Science and Technology Parks of Nanjing, in China锛宨n which there's a group of effective researchers, strict quality controllers, cordial customer care specialists and experienced professionals devoted towards the top quality, Cost-efficiency, Timely response and the maximization advantage of our clients.   we're worried about a persons introductio 
Tianjin Yaguang High-Tech Development Company:
 
shijiazhuang jike chemical co.,ltd:
 
Hangzhou Hangshen Energy-Saving Furnace Co.,Ltd:
Hangzhou Hangshen Energy-Saving Furnace Co.,Ltd. Is the production of energy-saving electric resistance furnace and of the professional manufacturers of industrial furnaces,Website:www.hzfurnaces.com, the first fastener industry association member units, zhejiang province, the company was founded in 1990, organized by super resistance to industrial company, hangzhou enterprise, in 1996 changed its name to hangzhou HangShen energy-saving furnaces co., LTD. Since its inception the company has always adhere to science and technology and the deepening reform. Over the years through the company all staff′s continuous efforts and explore, proud achievements obtained. Is district environmental protection bureau rated industrial furnace drainage standard. In recent years, my company in the center